(Q37387958)

20 August 2017

1 reference

title

Long-term experience with induction treatment regimens in multiple sclerosis (English)

1 reference

20 August 2017

0 references

Emmanuelle Le Page

1

1 reference

20 August 2017

Gilles Edan

series ordinal

2

1 reference

20 August 2017

publication date

1 February 2009

1 reference

Journal of the Neurological Sciences

20 August 2017

published in

1 reference

20 August 2017

volume

277 Suppl 1

1 reference

20 August 2017

page(s)

S46-9

1 reference

Therapeutic effect of mitoxantrone combined with methylprednisolone in multiple sclerosis: a randomised multicentre study of active disease using MRI and clinical criteria

20 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2809%2970013-9

Mitoxantrone in progressive multiple sclerosis: a placebo-controlled, double-blind, randomised, multicentre trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2809%2970013-9

Randomized placebo-controlled trial of mitoxantrone in relapsing-remitting multiple sclerosis: 24-month clinical and MRI outcome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2809%2970013-9

Mitoxantrone as induction therapy in aggressive relapsing remitting multiple sclerosis: a descriptive analysis of 100 consecutive patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2809%2970013-9

Mitoxantrone as induction treatment in aggressive relapsing remitting multiple sclerosis: treatment response factors in a 5 year follow-up observational study of 100 consecutive patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2809%2970013-9

10.1016/S0022-510X(09)70013-9

7 January 2021

Identifiers

DOI

1 reference

20 August 2017

1 reference